Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Barbieri

Showing results (271-280 of 305) with videos related to

Pageof 31
Sort By:
Nature Communications|March 16, 2025
Direct measurement of the male germline mutation rate in individuals using sequential sperm samplesJonathan E Shoag, Amoolya Srinivasa, Caitlin A Loh, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2013
Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnoverChuandong Geng, Bin He, Limei Xu, et al.
Breast (Edinburgh, Scotland)|May 7, 2013
Potential impact of the 70-gene signature in the choice of adjuvant systemic treatment for ER positive, HER2 negative tumors: a single institution experienceR Torrisi, C A Garcia-Etienne, A Losurdo, et al.
Cancer Discovery|July 5, 2024
Clonal Lineage Tracing with Somatic Delivery of Recordable Barcodes Reveals Migration Histories of Metastatic Prostate CancerRyan N Serio, Armin Scheben, Billy Lu, et al.
The Journal of Clinical Investigation|July 2, 2019
N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancerAdeline Berger, Nicholas J Brady, Rohan Bareja, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2010
Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocolS Ferrari, K Sundby Hall, R Luksch, et al.
Nature Communications|December 13, 2024
Canonical androgen response element motifs are tumor suppressive regulatory elements in the prostateXuanrong Chen, Michael A Augello, Deli Liu, et al.
Cancer Cell|April 2, 2019
CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate TumorigenesisMichael A Augello, Deli Liu, Lesa D Deonarine, et al.
Elife|September 17, 2015
SPOP mutation leads to genomic instability in prostate cancerGunther Boysen, Christopher E Barbieri, Davide Prandi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremitiesP Picci, T Böhling, G Bacci, et al.
Pageof 31

Showing results (271-280 of 305) with videos related to

Sort By:
Pageof 31
Nature Communications|March 16, 2025
Direct measurement of the male germline mutation rate in individuals using sequential sperm samplesJonathan E Shoag, Amoolya Srinivasa, Caitlin A Loh, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2013
Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnoverChuandong Geng, Bin He, Limei Xu, et al.
Breast (Edinburgh, Scotland)|May 7, 2013
Potential impact of the 70-gene signature in the choice of adjuvant systemic treatment for ER positive, HER2 negative tumors: a single institution experienceR Torrisi, C A Garcia-Etienne, A Losurdo, et al.
Cancer Discovery|July 5, 2024
Clonal Lineage Tracing with Somatic Delivery of Recordable Barcodes Reveals Migration Histories of Metastatic Prostate CancerRyan N Serio, Armin Scheben, Billy Lu, et al.
The Journal of Clinical Investigation|July 2, 2019
N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancerAdeline Berger, Nicholas J Brady, Rohan Bareja, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2010
Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocolS Ferrari, K Sundby Hall, R Luksch, et al.
Nature Communications|December 13, 2024
Canonical androgen response element motifs are tumor suppressive regulatory elements in the prostateXuanrong Chen, Michael A Augello, Deli Liu, et al.
Cancer Cell|April 2, 2019
CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate TumorigenesisMichael A Augello, Deli Liu, Lesa D Deonarine, et al.
Elife|September 17, 2015
SPOP mutation leads to genomic instability in prostate cancerGunther Boysen, Christopher E Barbieri, Davide Prandi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremitiesP Picci, T Böhling, G Bacci, et al.
Pageof 31